EUVIMEDDescoperă EUVIMED
Kommentar

What Makes an Estimand Useful? Guidance on the Choice of Intercurrent Event Strategies

Brennan C Kahan iD, Fan Li iD, Michael O Harhay iD, Suzie Cro iD

Statistics in Medicine · 2026-03 · 45 (6-7)

DOI: 10.1002/sim.70452 ↗

At a glance

Kommentar in Statistics in Medicine, published online on 2026-03-18. Written by Brennan C Kahan and 3 co-authors. Institution: MRC Clinical Trials Unit at UCL, London, UK. Major MEDLINE topics: Randomized Controlled Trials as Topic. Cited 4 times so far (Crossref); 24 references. Funded by: Medical Research Council, NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

While the use of estimands in randomized trials is increasing, there is little guidance on which intercurrent event strategies should be used. The article by Fleming et al. seeks to address this gap. They argue that strategies such as hypothetical, principal stratum, and while‐alive generally cannot be used to reliably inform decision making, and that treatment policy (and composite for mortality) strategies should be used instead. In this Commentary we argue that there are a variety of settings where strategies such as hypothetical, principal stratum, and while‐alive can reliably inform decision‐making and are preferable to a treatment policy strategy. We provide an alternative approach for selecting intercurrent event strategies, which systematically considers the trade‐off between relevance (whether it addresses a useful question) and reliability (the ability to be estimated such that stakeholders can have confidence in the results) of each strategy in order to identify those that can be used to robustly inform decision‐making. Our overall conclusion is that there is no single intercurrent event strategy that is appropriate in all settings; all strategies can be beneficial when used in appropriate settings, but harmful when used in inappropriate settings.

Subjects

MeSH terms (MEDLINE)

Randomized Controlled Trials as TopicHumansDecision MakingReproducibility of Results

Author keywords

choice of intercurrent event strategycompositeestimandhypotheticalprincipal stratumtreatment policywhile‐alive

Authors and institutions

  • MRC Clinical Trials Unit at UCL, London, UK.
  • Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, USA.
  • Center for Methods in Implementation and Prevention Science, Yale University School of Public Health, New Haven, Connecticut, USA.
  • Center for Clinical Trials Innovation, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Imperial Clinical Trials Unit, School of Public Health, Imperial College London, London, UK.

ORCID profiles: Brennan C Kahan, Fan Li, Michael O Harhay, Suzie Cro

Funding

  • Medical Research Council
  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute

Cite

APA

Kahan, B. C., Li, F., Harhay, M. O., & Cro, S. (2026). What Makes an Estimand Useful? Guidance on the Choice of Intercurrent Event Strategies. Statistics in Medicine, 45(6-7). https://doi.org/10.1002/sim.70452

Vancouver

Kahan BC, Li F, Harhay MO, Cro S. What Makes an Estimand Useful? Guidance on the Choice of Intercurrent Event Strategies. Statistics in Medicine. 2026;45(6-7). doi:10.1002/sim.70452

BibTeX
@article{Kahan2026,
  author = {Kahan, Brennan C and Li, Fan and Harhay, Michael O and Cro, Suzie},
  title = {What Makes an Estimand Useful? Guidance on the Choice of Intercurrent Event Strategies},
  journal = {Statistics in Medicine},
  year = {2026},
  volume = {45},
  number = {6-7},
  doi = {10.1002/sim.70452}
}
Start for free →